Marjorie Zauderer

Marjorie Zauderer

UNVERIFIED PROFILE

Are you Marjorie Zauderer?   Register this Author

Register author
Marjorie Zauderer

Marjorie Zauderer

Publications by authors named "Marjorie Zauderer"

Are you Marjorie Zauderer?   Register this Author

47Publications

1233Reads

17Profile Views

Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.

Am J Ind Med 2020 Feb 19;63(2):105-114. Epub 2019 Nov 19.

Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajim.23062DOI Listing
February 2020

Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas.

J Thorac Oncol 2019 Dec 28. Epub 2019 Dec 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.12.111DOI Listing
December 2019

Nivo-lution in Mesothelioma.

Clin Cancer Res 2019 Sep 17;25(18):5438-5440. Epub 2019 Jul 17.

Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744981PMC
September 2019

Practical Application of Real-World Evidence in Developing Cancer Therapies.

JCO Clin Cancer Inform 2019 07;3:1-2

Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.19.00071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873932PMC
July 2019

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma.

Genome Med 2019 03 26;11(1):18. Epub 2019 Mar 26.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-019-0631-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436227PMC
March 2019

Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy.

Immunotherapy 2017 09;9(11):913-927

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810850PMC
September 2017

Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses Loss-Driven Tumorigenesis.

Mol Cancer Ther 2017 08 3;16(8):1693-1704. Epub 2017 May 3.

Department of Cancer Biology and David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0821DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929164PMC
August 2017

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.

J Clin Oncol 2016 08 20;34(23):2761-8. Epub 2016 Jun 20.

Andreas Rimner, Marjorie G. Zauderer, Prasad S. Adusumilli, Preeti K. Parhar, Abraham J. Wu, Kaitlin M. Woo, Ronglai Shen, Michelle S. Ginsberg, Ellen D. Yorke, Kenneth E. Rosenzweig, Valerie W. Rusch, and Lee M. Krug, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, NY; and Daniel R. Gomez, David C. Rice, and Anne S. Tsao, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.2675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019761PMC
August 2016

A new standard for malignant pleural mesothelioma.

Lancet 2016 Apr 21;387(10026):1352-1354. Epub 2015 Dec 21.

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)01311-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464401PMC
April 2016

Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.

J Thorac Oncol 2016 Feb 10;11(2):249-55. Epub 2015 Dec 10.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917284PMC
February 2016

Localized malignant pleural mesothelioma with renal metastasis.

Oxf Med Case Reports 2015 Jan 14;2015(1):170-2. Epub 2015 Jan 14.

Department of Medical Oncology , Royal North Shore Hospital , Sydney, NSW , Australia ; Sydney Medical School , University of Sydney , Sydney, NSW , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/omcr/omu064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369975PMC
January 2015

Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.

Int J Radiat Oncol Biol Phys 2014 Oct 26;90(2):394-401. Epub 2014 Jul 26.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2014.05.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560169PMC
October 2014

A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers.

J Thorac Oncol 2014 Sep;9(9):1272-7

*Memorial Sloan Kettering Cancer Center, New York, NY; †Tokyo Medical and Dental University, Tokyo, Japan; and ‡Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133740PMC
September 2014

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma.

Lung Cancer 2014 Jun 14;84(3):271-4. Epub 2014 Mar 14.

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343315PMC
June 2014

Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.

J Thorac Oncol 2013 Nov;8(11):1430-3

*Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; †Department of Medicine, Weill Cornell Medical College, New York, New York; ‡Departments of Pathology, §Surgery, ‖Epidemiology and Biostatistics, ¶Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829e7ef9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343301PMC
November 2013

Important recent insights into the genetics and biology of malignant pleural mesothelioma.

Ann Cardiothorac Surg 2012 Nov;1(4):462-5

Department of Pathology and Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; ; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2225-319X.2012.10.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741788PMC
November 2012

Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery.

Ann Cardiothorac Surg 2012 Nov;1(4):487-90

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2225-319X.2012.10.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741800PMC
November 2012

New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.

Clin Cancer Res 2012 Sep 23;18(17):4485-90. Epub 2012 Jul 23.

Departments of Pathology and Human Oncology & Pathogenesis Program, Surgery, and Cell Biology Program, Memorial Sloan-Kettering Cancer Center, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432735PMC
September 2012

Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Int J Radiat Oncol Biol Phys 2012 Jul 18;83(4):1278-83. Epub 2012 May 18.

Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.09.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359620PMC
July 2012

Novel therapies in phase II and III trials for malignant pleural mesothelioma.

J Natl Compr Canc Netw 2012 Jan;10(1):42-7

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4343316PMC
http://dx.doi.org/10.6004/jnccn.2012.0007DOI Listing
January 2012

The evolution of multimodality therapy for malignant pleural mesothelioma.

Curr Treat Options Oncol 2011 Jun;12(2):163-72

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-011-0146-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321839PMC
June 2011

Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.

Breast Cancer Res Treat 2009 Sep 13;117(1):205-10. Epub 2008 Jul 13.

NewYork-Presbyterian Hospital, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0116-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811071PMC
September 2009

Developing a cancer-specific geriatric assessment: a feasibility study.

Cancer 2005 Nov;104(9):1998-2005

Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21422
Publisher Site
http://dx.doi.org/10.1002/cncr.21422DOI Listing
November 2005

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Breast Cancer Res Treat 2005 Jul;92(2):151-6

Memorial Sloan-Kettering Cancer Center, NY 10021, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-1410-8DOI Listing
July 2005